Treating Metastatic Squamous Cell Esophageal Cancer

What is Metastatic Squamous Cell Esophageal Cancer?

Metastatic squamous cell esophageal cancer is a type of esophageal cancer that originates in the squamous cells lining the esophagus and has spread beyond the esophagus to other parts of the body. This aggressive cancer is often diagnosed at a late stage, making treatment challenging and prognosis poor.

How Metastatic Esophageal Cancer Impacts Health and Quality of Life

Patients with metastatic esophageal cancer experience a range of symptoms, including difficulty swallowing (dysphagia), weight loss, pain, and fatigue. The disease can significantly impact nutrition, physical strength, and emotional well-being. As the cancer spreads, it may affect vital organs, leading to complications that further diminish quality of life.

The diagnosis of metastatic disease often brings uncertainty and distress, both for patients and their families. Treatment goals shift from cure to prolonging survival, managing symptoms, and maintaining the best possible quality of life.

Innovative Treatment Options

Recent advances in the treatment of metastatic squamous cell esophageal cancer have improved outcomes for many patients. Standard therapies include:

• Chemotherapy: Often the first-line treatment, chemotherapy can shrink tumors and relieve symptoms.
• Immunotherapy: Drugs have shown promise in targeting cancer cells by harnessing the body’s immune system.
• Targeted Therapy: Some patients may benefit from drugs that target specific genetic mutations or pathways involved in cancer growth.
• Radiation Therapy: Used to control symptoms and reduce tumor size in certain cases.
• Supportive Care: Nutritional support, pain management, and psychological counseling are essential components of comprehensive care.

STERIS’s truFreeze Cryotherapy: A New Option for Metastatic Squamous Cell Esophageal Cancer

A promising innovation in the treatment and/or palliation of metastatic squamous cell esophageal cancer is STERIS’s truFreeze™ Spray Cryotherapy System. This technology uses ultra-cold liquid nitrogen, delivered via a specialized catheter during endoscopy, to flash-freeze and destroy malignant cells in the esophagus. Unlike heat-based ablation therapies, truFreeze preserves the underlying tissue structure, promoting healing and minimizing scarring.

TruFreeze cryotherapy has been evaluated in several clinical trials, demonstrating safety, efficacy in dysphagia relief, and improved quality of life for patients with advanced esophageal cancer.¹²³⁴

• Minimally Invasive: The procedure is performed endoscopically, making it suitable for patients who may not be candidates for surgery.
• Symptom Relief: Clinical studies and patient experiences show significant improvement in swallowing (dysphagia) and overall quality of life.
• Tumor Reduction: truFreeze can shrink tumor masses, helping to clear obstructions in the esophagus and delay or prevent the need for stent placement.
• Palliative Care: For those with advanced disease, truFreeze offers a way to manage symptoms and maintain daily activities, even when other treatments are no longer effective.

Beating the Odds of Esophageal Cancer: A Powerful Patient Story

Harold, diagnosed with stage IV metastatic esophageal cancer, faced severe dysphagia and was told he had only months to live. After beginning regular truFreeze treatments, Harold experienced a remarkable turnaround: he regained the ability to eat, his pain lessened, and he returned to his normal activities. Nearly two years after his diagnosis, Harold described truFreeze as “giving him life and longevity,” allowing him to enjoy meaningful moments with his family and maintain independence. His story exemplifies how innovative therapies like truFreeze can transform lives, offering hope and improved quality of life even in advanced disease. As of December, 2025, Harold is four years post diagnosis and doing well.

Life-Changing Impact of truFreeze Cryotherapy

While metastatic squamous cell esophageal cancer remains a serious diagnosis, advances in therapy have led to meaningful improvements for many patients. Some have experienced prolonged survival, better symptom control, and the ability to participate in daily activities that matter most to them.